e-learning
resources
Glasgow 2004
Monday 06.09.2004
Cardiovascular and metabolic consequences of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome
K. Kobayashi, Y. Nishimura, T. Shimada, T. Takeda, H. Kamiryo, R. Matsuoka, K. Takenaka, D. Kasai, Y. Urata, T. Nishiuma, M. Satouchi, M. Yokoyama (Kobe, Japan)
Source:
Annual Congress 2004 - Cardiovascular and metabolic consequences of OSA
Session:
Cardiovascular and metabolic consequences of OSA
Session type:
Thematic Poster Session
Number:
2094
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Kobayashi, Y. Nishimura, T. Shimada, T. Takeda, H. Kamiryo, R. Matsuoka, K. Takenaka, D. Kasai, Y. Urata, T. Nishiuma, M. Satouchi, M. Yokoyama (Kobe, Japan). Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome. Eur Respir J 2004; 24: Suppl. 48, 2094
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Bronchial reactivity in patients with obstructive sleep apnea syndrome treated with continuous positive airway pressure
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005
Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004
Amelioration of immune system activation in obstructive sleep apnea syndrome patients after continuous positive airway pressure treatment
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea
Source: Eur Respir J 2008; 32: 1009-1015
Year: 2008
Effect and significance of continuous positive airway pressure treatment on vascular endothelial function in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003
Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006
Liver function following continuous positive airway pressure therapy in obstructive sleep apnea patients
Source: International Congress 2017 – CPAP therapy
Year: 2017
Falls in blood pressure in patients with obstructive sleep apnea syndrome after long-term nasal continuous positive airway pressure treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005
Predictors of continuous positive airway pressure adherence in obstructive sleep apnea syndrome
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke
Source: Eur Respir J 2001; 18: 623-629
Year: 2001
Angiogenic factors in obstructive sleep apnea syndrome (OSA). Effects of nasal continuous positive airway pressure treatment (CPAP)
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010
Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Humidified nasal continuous positive airway pressure in obstructive sleep apnoea
Source: Eur Respir J 2003; 22: 258-262
Year: 2003
Continuous positive airway pressure in patients with obstructive sleep apnea: Age-dependent adherence
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Titration of continuous positive airway pressure in Chinese patients with obstructive sleep apnea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP
Source: Eur Respir J 2007; 30: 496-500
Year: 2007
Evaluation of continuous positive airway pressure compliance in a group of obstructive sleep apnea patients
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept